Moreover, blocking the CSF1/CSF1R axis reduces mesothelioma growth and improves anti-PDL1 immunotherapy efficacy [101], and CSF1R inhibition minimizes the development of cervical and mammary tumors in mice by lowering TAMs turnover and increasing the CD8+ T-cell infiltration [102]. Here, CSF1R is linked to mesothelioma.